Korean J Urol.  1981 Apr;22(2):195-199.

A Clinical Observation of the Intravesical Thiotepa in Bladder Cancer

• Min KS
• Park KH

Abstract

Primary transitional cell carcinoma of the bladder was treated with prophylactic and therapeutic Intravesical thiotepa in 7 cases. In 5 cases of stage A tumor, postoperative follow up was averaged 10.8 months and 4 cases were tumor free (80%). In 2 cases of infiltrating tumor, the instillation was not effective. Thiotepa can be given safely in the 7 days post-operative period and no leukopenia and bladder irritation symptoms were occurred.

Keyword

Intravesical chemotherapy; thiotepa; bladder cancer

MeSH Terms

Carcinoma, Transitional Cell
Follow-Up Studies
Leukopenia
Thiotepa*
Urinary Bladder Neoplasms*
Urinary Bladder*
Thiotepa